Literature DB >> 11383973

Schizophrenia, a neurodegenerative disorder with neurodevelopmental antecedents.

P C Ashe1, M D Berry, A A Boulton.   

Abstract

Schizophrenia is a devastating disorder that has been referred to as youth's greatest disabler. Although a number of hypotheses have been proposed in an attempt to explain the pathophysiology of schizophrenia no single theory seems to account for all facets of the disease. Each hypothesis explains some of the phenomena associated with schizophrenia and it is probable that many variables described in these hypotheses interact to produce a disorder characterized by heterogeneous symptomatology, progression and prognosis. Compelling evidence suggests that the primary disturbance is a neurodevelopmental abnormality, possibly resulting from a genetic defect(s), resulting in a predisposition to schizophrenia. Events later in life may then lead to the presentation of symptoms and a subsequent progression of the disease. Recent evidence suggests that the progressive course of schizophrenia is associated with ongoing neurodegenerative processes. Changes in brain derived neurotrophic factor (BDNF) may explain the various changes observed in schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11383973     DOI: 10.1016/s0278-5846(01)00159-2

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  29 in total

1.  Alternative complement pathway in schizophrenia.

Authors:  Anna Boyajyan; Aren Khoyetsyan; Andranik Chavushyan
Journal:  Neurochem Res       Date:  2010-01-26       Impact factor: 3.996

2.  Intrinsic sensory deprivation induced by neonatal capsaicin treatment induces changes in rat brain and behaviour of possible relevance to schizophrenia.

Authors:  Penny Newson; Ann Lynch-Frame; Rebecca Roach; Sarah Bennett; Vaughan Carr; Loris A Chahl
Journal:  Br J Pharmacol       Date:  2005-10       Impact factor: 8.739

Review 3.  Viral infection, inflammation and schizophrenia.

Authors:  Rachel E Kneeland; S Hossein Fatemi
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2012-02-10       Impact factor: 5.067

Review 4.  Corticosteroids, immune suppression, and psychosis.

Authors:  Dana C Perantie; E Sherwood Brown
Journal:  Curr Psychiatry Rep       Date:  2002-06       Impact factor: 5.285

5.  Schizophrenia as segmental progeria.

Authors:  Evangelos Papanastasiou; Fiona Gaughran; Shubulade Smith
Journal:  J R Soc Med       Date:  2011-11       Impact factor: 5.344

6.  Development of a cost-efficient novel method for rapid, concurrent genotyping of five common single nucleotide polymorphisms of the brain derived neurotrophic factor (BDNF) gene by tetra-primer amplification refractory mutation system.

Authors:  Cathy K Wang; Michael S Xu; Colin J Ross; Ryan Lo; Ric M Procyshyn; Fidel Vila-Rodriguez; Randall F White; William G Honer; Alasdair M Barr
Journal:  Int J Methods Psychiatr Res       Date:  2015-06-29       Impact factor: 4.035

7.  Cognition in young schizophrenia outpatients: comparison of first-episode with multiepisode patients.

Authors:  Yoram Braw; Yuval Bloch; Shlomo Mendelovich; Gideon Ratzoni; Gilad Gal; Hagai Harari; Asaf Tripto; Yechiel Levkovitz
Journal:  Schizophr Bull       Date:  2007-11-05       Impact factor: 9.306

8.  Brain-derived neurotrophic factor gene variation influences cerebrospinal fluid 3-methoxy-4-hydroxyphenylglycol concentrations in healthy volunteers.

Authors:  Erik G Jönsson; Peter Saetre; Bodil Edman-Ahlbom; Anna Sillén; Agneta Gunnar; Dimitrios Andreou; Ingrid Agartz; Göran Sedvall; Håkan Hall; Lars Terenius
Journal:  J Neural Transm (Vienna)       Date:  2008-09-10       Impact factor: 3.575

Review 9.  The role of the extracellular signal-regulated kinase pathway in cerebellar abnormalities in schizophrenia.

Authors:  Svetlana V Kyosseva
Journal:  Cerebellum       Date:  2004       Impact factor: 3.847

10.  BDNF and TNF-α polymorphisms in memory.

Authors:  B S Yogeetha; L M Haupt; K McKenzie; H G Sutherland; R K Okolicsyani; R A Lea; B H Maher; R C K Chan; D H K Shum; L R Griffiths
Journal:  Mol Biol Rep       Date:  2013-08-06       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.